Actavis said in a statement it was ready to continue its efforts in accordance with the Croatian law on the takeover of shareholding companies and all other Croatian laws and regulations and HANFA's rules.
According to the statement, over the past few months the Icelandic firm has contacted Pliva's management several times with friendly intentions and is still open to consensus.
Actavis said that, acting in good faith, it had submitted, at Pliva's request, a highly competitive bid that exceeded the price of the bid supported by Pliva's Supervisory Board in its press release of 27 June 2006.
The Icelandic company expressed its concern over the fact that Pliva's management decided to side with one bidder during talks with interested parties, adding that this was not in the best interests of Pliva's shareholders.
Actavis said it was confident that the Croatian government would ensure that all the parties fully complied with the takeover law and other applicable rules and regulations.
Actavis's rival, US company Barr Pharmaceuticals, announced in Croatian newspapers on Monday its intention to publish a takeover bid for Pliva, saying it would make a bid for the acquisition of all of Pliva's shares within the time limit set by law.